German Cannabis Legalization

BGH ruling could reshape how online platforms market medical cannabis treatments The Federal Court of Justice (Bundesgerichtshof, BGH) in Karlsruhe is hearing arguments today that could fundamentally alter the medical cannabis landscape in Germany. At stake: whether online platforms can legally advertise medical cannabis treatments, or if such marketing violates the country’s strict Heilmittelwerbegesetz (Therapeutic […]

es gibt Wochenenden, die die politische Landschaft verändern. Das vergangene war eines davon. Nach der brisanten Anhörung im Gesundheitsausschuss am Donnerstag und einem kontroversen SZ-Kommentar am Wochenende steht eines fest: Die Cannabis-Debatte ist kein Nebenschauplatz mehr – sie ist zum Lackmustest für die politische Kultur in Deutschland geworden. Lassen Sie mich die Ereignisse einordnen und

There are people who shape an industry not by being the loudest voice in the room, but by being the one who brings everyone to the table. Peter was one of those people who really had an impact on the industry. Therefore we put him on the spotlight and produced a documentary. The early days

Berlin, November 2025 – For one weekend each year, the beating heart of Germany’s cannabis community gathers under one roof. The Cannabis Normal! Conference, hosted by the Deutscher Hanfverband (DHV), returns from November 21–23 to Rykestraße 13 in Berlin’s Prenzlauer Berg district, uniting activists, scientists, policymakers, and entrepreneurs to debate the future of cannabis regulation.

Why Companies are united and Politicians Are Alarmed – and Why the Petition Is Gaining Momentum! Germany – Europe’s largest medical cannabis market – has entered its most critical phase in years. In mid-July, the German Ministry of Health (BMG) presented a new draft amendment to the Medical Cannabis Law (MedCanG). Despite heavy criticism from

Germany’s medical cannabis landscape is facing a dramatic regulatory shift as Health Minister Nina Warken (CDU) moves to reverse the liberal policies implemented by her predecessor Karl Lauterbach (SPD). The proposed restrictions come at a time when Germany has established itself as the world’s largest medical cannabis market, creating a striking contradiction between policy tightening

Germany’s new Federal Drug Commissioner, Hendrik Streeck (CDU), has once again placed the country’s cannabis rules under scrutiny. In an interview he argued the law is “not consistent and coherent,” pointing directly to the allowance of three home-grown plants per adult. Under the right conditions, he suggested, such a harvest could amount to up to

High Tide’s decision to acquire 51% of Remexian Pharma for a preliminary €27.2 million isn’t just another headline; it’s a calculated entry into Europe’s largest medical cannabis market with a player that already moves real volume and runs a fully certified EU-GDP warehouse. The agreement includes an option to buy the remaining stake and is

For years, the assumption in the German cannabis market was clear: if a prescription came through an online platform — usually operated from abroad — the risk lay with the telemedicine provider, not the pharmacy. That legal comfort zone has now been shattered. A new legal opinion commissioned by the Association of Cannabis Dispensing Pharmacies